We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$27.3B
AUM Growth
+$2.66B
Cap. Flow
-$789M
Cap. Flow %
-2.89%
Top 10 Hldgs %
40.16%
Holding
98
New
18
Increased
23
Reduced
21
Closed
19

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$955M
2
UNH icon
UnitedHealth
UNH
+$745M
3
XYZ
Block Inc
XYZ
+$545M
4
AMZN icon
Amazon
AMZN
+$536M
5
PPG icon
PPG Industries
PPG
+$416M

Sector Composition

Rank Sector Weight
1 Healthcare 28.89%
2 Financials 21.6%
3 Industrials 15.25%
4 Technology 11.5%
5 Communication Services 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAM icon
51
EPAM Systems
EPAM
$5.15B
$110M 0.4%
368,708
-549,789
-60% -$140M
CSX icon
52
CSX Corp
CSX
$92.5B
$109M 0.4%
3,133,913
-7,506,915
-71% -$239M
TEAM icon
53
Atlassian
TEAM
$39.1B
$104M 0.38%
+435,946
New +$85.6M
PHVS icon
54
Pharvaris
PHVS
$2.41B
$103M 0.38%
3,656,923
+425,000
+13% +$8.6M
RRX icon
55
Regal Rexnord
RRX
$11.5B
$102M 0.38%
+691,717
New +$87.3M
FDMT icon
56
4D Molecular Therapeutics
FDMT
$600M
$97M 0.36%
4,787,914
KDP icon
57
Keurig Dr Pepper
KDP
$39.7B
$96.2M 0.35%
2,886,871
+598,610
+26% +$18.7M
VKTX icon
58
Viking Therapeutics
VKTX
$3.94B
$95.8M 0.35%
5,145,112
+571,796
+13% +$7.48M
NAMS icon
59
NewAmsterdam Pharma
NAMS
$3.3B
$89.6M 0.33%
8,024,565
BEKE icon
60
KE Holdings
BEKE
$18.7B
$85.7M 0.31%
5,285,000
+665,000
+14% +$10.3M
LLY icon
61
Eli Lilly
LLY
$1.08T
$80.9M 0.3%
+138,728
New +$81M
IFF icon
62
International Flavors & Fragrances
IFF
$21.7B
$77.2M 0.28%
953,384
-1,113,676
-54% -$80.5M
SYK icon
63
Stryker
SYK
$134B
$74.5M 0.27%
+248,913
New +$69.9M
EWTX icon
64
Edgewise Therapeutics
EWTX
$4.81B
$67.4M 0.25%
6,159,146
CDNS icon
65
Cadence Design Systems
CDNS
$90.2B
$62.2M 0.23%
228,482
-1,424,748
-86% -$367M
ZLAB icon
66
Zai Lab
ZLAB
$2.92B
$51.1M 0.19%
1,869,283
-621,720
-25% -$16.4M
MRSH
67
Marsh
MRSH
$91.3B
$45M 0.17%
+237,706
New +$45.9M
AMLX icon
68
Amylyx Pharmaceuticals
AMLX
$2.63B
$43.6M 0.16%
2,962,555
PCOR icon
69
Procore
PCOR
$8.93B
$42.5M 0.16%
+613,437
New +$37.8M
DAWN
70
DELISTED
Day One Biopharmaceuticals
DAWN
$37.4M 0.14%
2,558,563
FL
71
DELISTED
Foot Locker
FL
$33.4M 0.12%
1,073,749
-1,161,707
-52% -$28M
CZOO
72
DELISTED
Cazoo Group Ltd
CZOO
$20.4M 0.07%
+2,142,728
New +$73.9M
VSTM icon
73
Verastem
VSTM
$638M
$20M 0.07%
2,456,292
LIAN
74
DELISTED
LianBio American Depositary Shares
LIAN
$15.9M 0.06%
3,564,173
PEPG icon
75
PepGen
PEPG
$201M
$10.1M 0.04%
1,482,434

Similar funds

Viking Global Investors's Q4 2023 Portfolio in Review

As of Q4 2023, Viking Global Investors held 98 positions worth $27.3B, up 11% from $24.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Viking Global Investors's Q4 2023 filing shows 18 new, 23 increased, 21 reduced and 19 closed positions. Its largest new stake was Advanced Micro Devices: 4,737,399 shares worth $698M. The largest sale was Microsoft, an estimated $955M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.

  • Viking Global Investors's largest Q4 2023 buy was Advanced Micro Devices: 4,737,399 shares worth $698M.
  • Viking Global Investors added most to Progressive in Q4 2023, an estimated $739M increase.
  • Viking Global Investors's biggest Q4 2023 reduction was UnitedHealth, cutting an estimated $745M.
  • Viking Global Investors fully exited Microsoft in Q4 2023, selling an estimated $955M.
  • Viking Global Investors's ten largest holdings make up 40% of its $27.3B portfolio in Q4 2023.
  • Viking Global Investors opened 18 new positions and closed 19 in Q4 2023.
  • Viking Global Investors's portfolio value rose 11% quarter-over-quarter to $27.3B.

Based on Viking Global Investors's 13F filing for Q4 2023, filed 14 Feb 2024.